PBSwitch
Monthly · October 2026

Formulary Moves

What changed on Medicare Part D formularies this month, from public CMS files.

Drug moves

observed

CMS Part D formulary files, September 2026 vs August 2026. Files dated September 16, 2026 and August 19, 2026; 328 formularies in both files.

  1. Insulin Glargine-Yfgn
    Added to 7 formularies
    7
    observed
  2. Breztri Aerosphere
    Added to 1 formulary
    1
    observed
  3. Janumet
    Added to 1 formulary
    1
    observed
  4. Janumet Xr
    Added to 1 formulary
    1
    observed
  5. Ventolin Hfa
    Added to 1 formulary
    1
    observed

Employer plans

observed
4

employer plans switched to a carrier with a different pharmacy benefit manager this month, across 3 states.

Carrier employer network files, October 2026 vs September 2026. The carrier switch is observed in the public files. For all 4 the pharmacy benefit change is inferred from the carrier, since an employer can carve its drug benefit out to another PBM.

Which employers? Employer names, states and the pharmacy benefit managers on both sides of each switch are coming to signed in PBSwitch accounts. Create a free account to be first in line.

How this is built

  • Drug moves compare two CMS monthly Part D formulary files, formulary by formulary, for the 500 most prescribed Part D drugs by 2024 Medicare claims (485 of them appear on formularies in the newer file). A move is a drug that appears on, or disappears from, a formulary present in both files.
  • Employer switches compare public employer network files from two large commercial carriers month over month. A switch is an employer plan that leaves one carrier and joins the other in the same month.
  • No plan names, tiers or patient data on this page. Facts only: this page does not recommend any drug, plan or benefit design. Read the method.

Not medical advice. This page describes insurance coverage data and policy documents. It is not medical, legal, or benefits advice, and it is not a recommendation to take, prescribe, or switch any medication. Talk to your doctor or pharmacist about treatment decisions.

Not a coverage guarantee. Coverage, tier, prior authorization, step therapy, and quantity-limit data are compiled from CMS public files and plan documents dated September 16, 2026. Plans change formularies during the year and individual coverage depends on your specific plan, pharmacy, and coverage phase. Always verify with your plan's current formulary documents or by calling the number on your member ID card. Medicare beneficiaries can compare plans at Medicare.gov or 1-800-MEDICARE.

PBSwitch is a private company. We are not connected with or endorsed by the U.S. government, the federal Medicare program, or any insurance plan or drug manufacturer. Sources: CMS monthly Part D formulary file of September 16, 2026, CMS monthly Part D formulary file of August 19, 2026, carrier employer network files (Transparency in Coverage), October 2026 and September 2026. Methodology: compiled from the public source files cited above. Clinical review by a PharmD is in progress. Page updated 2026-10-21.

PBSwitch publishes plan- and policy-level data only. We hold no patient-level or claims-level identifiable data.